Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience (2020)
- Authors:
- Autor USP: CASTRO JUNIOR, GILBERTO DE - FM
- Unidade: FM
- DOI: 10.6061/clinics/2020/e1615
- Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO; PERÍODO PÓS-OPERATÓRIO; ESTUDOS RETROSPECTIVOS; TAXA DE SOBREVIVÊNCIA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
FRANCO, Rejane et al. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1615. Acesso em: 01 jun. 2024. -
APA
Franco, R., Matos, L. L. de, Kulcsar, M. A. V., Castro Junior, G. de, & Marta, G. N. (2020). Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience. Clinics, 75. doi:10.6061/clinics/2020/e1615 -
NLM
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2024 jun. 01 ] Available from: https://doi.org/10.6061/clinics/2020/e1615 -
Vancouver
Franco R, Matos LL de, Kulcsar MAV, Castro Junior G de, Marta GN. Influence of time between surgery and postoperative radiation therapy and total treatment time in locoregional control of patients with head and neck cancer: a single center experience [Internet]. Clinics. 2020 ; 75[citado 2024 jun. 01 ] Available from: https://doi.org/10.6061/clinics/2020/e1615 - Diagnóstico de mutações ativadoras do gene EGFR em adenocarcinomas pulmonares: caracterização e implicações clínicas
- Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study
- Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
- Manual de oncologia torácica
- Lung Cancer in Brazil [Editorial]
- Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Noções de oncologia torácica
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by programmed death Ligand-1 combined positive score
Informações sobre o DOI: 10.6061/clinics/2020/e1615 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
